The AHA today expressed support for and urged all senators to support an amendment to the Labor, Health and Human Services and Education appropriations bill that would help address the out-of-control cost of prescription drugs. Offered by Sens. Dick Durbin (D-IL) and Chuck Grassley (R-IA), amendment #3787 would provide funding to enable HHS to require disclosure of drug pricing information in direct-to-consumer advertising. “DTC advertising has the potential to lead to overutilization of high-cost prescription drugs, including when lower-cost but equally effective options may be available,” AHA wrote in a letter to senators. “This is contributing to the unsustainable rate of growth in prescription drug spending, which is consuming a bigger portion of health care dollars each year. Requiring disclosure of drug pricing information in DTC advertising will meaningfully enhance drug pricing transparency and provide useful information for consumers as they engage in discussions with their providers about the best treatment options for their individual health care needs.”

Related News Articles

Headline
The departments of Health and Human Services and the Treasury Friday approved a Section 1332 waiver for Montana to implement a five-year reinsurance program…
Headline
Health and Human Services Secretary Alex Azar today released a plan outlining two pathways the administration intends to explore to safely import certain drugs…
Headline
The Senate Finance Committee today voted 19-9 to pass the Prescription Drug Pricing Reduction Act, legislation to reduce drug costs.
Headline
Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., today released a description of the chairman’s mark, the…
Headline
The House Energy and Commerce Committee today approved legislation to address surprise medical bills and Medicaid disproportionate share hospital cuts.
Blog
A recent American Enterprise Institute blog on hospital prices fails to capture the full story on how hospitals and health systems have slowed price growth.